Eli Lilly (LLY) EBT Margin (2009 - 2026)
Eli Lilly (LLY) reported EBT Margin of 40.25% for Q2 2026, down 3.31 percentage points from 43.56% a year earlier and down 4.45 percentage points from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eli Lilly's EBT Margin came in at 42.17%, up 10.51 percentage points year-over-year; for FY2025, it came in at 39.48%, up 11.33 percentage points from FY2024.
- EBT Margin has a five-year change of +10.02 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 28.15% in FY2024 (+8.94 pp), 19.21% in FY2023 (-4.64 pp), 23.85% in FY2022 (+2.11 pp) and 21.74% in FY2021 (-7.73 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBT Margin since Q1 2025.
- Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +9.69 percentage points.
- The high point for year-over-year EBT Margin in five years was Q3 2025 (a gain of 27.21 percentage points); the low point was Q3 2023 (a drop of 18.05 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 44.70% (Q1 2026), 42.85% (Q4 2025) and 41.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -4.34% |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn | 41.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.25% |
| Mar 31, 2026 | 44.70% |
| Dec 31, 2025 | 42.85% |
| Sep 30, 2025 | 41.09% |
| Jun 30, 2025 | 43.56% |
| Mar 31, 2025 | 27.15% |
| Dec 31, 2024 | 37.23% |
| Sep 30, 2024 | 13.89% |
| Jun 30, 2024 | 31.12% |
| Mar 31, 2024 | 28.92% |
| Dec 31, 2023 | 26.82% |
| Sep 30, 2023 | 4.50% |
| Jun 30, 2023 | 25.13% |
| Mar 31, 2023 | 21.98% |
| Dec 31, 2022 | 28.71% |
| Sep 30, 2022 | 22.55% |
| Jun 30, 2022 | 16.81% |
| Mar 31, 2022 | 26.29% |
| Dec 31, 2021 | 23.00% |
| Sep 30, 2021 | 18.39% |
API Access
Eli Lilly EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();